Neogen (NEOG) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -26.75% |
| Nov 30, 2025 | -24.59% |
| Aug 31, 2025 | 18.04% |
| May 31, 2025 | -108.55% |
| Feb 28, 2025 | -23.68% |
| Nov 30, 2024 | -97.48% |
| Aug 31, 2024 | -23.39% |
| May 31, 2024 | -18.56% |
| Feb 29, 2024 | -16.59% |
| Nov 30, 2023 | -17.26% |
| Aug 31, 2023 | -37.08% |
| May 31, 2023 | -20.50% |
| Feb 28, 2023 | -13.16% |
| Nov 30, 2022 | -34.73% |
| Aug 31, 2022 | -15.28% |
| May 31, 2022 | 3.67% |
| Feb 28, 2022 | -12.11% |
| Nov 30, 2021 | -0.62% |
| Aug 31, 2021 | 11.44% |
| May 31, 2021 | 2.16% |
| Feb 28, 2021 | 10.05% |
| Nov 30, 2020 | 11.68% |
| Aug 31, 2020 | 11.29% |
| May 31, 2020 | 11.62% |
| Feb 29, 2020 | 10.49% |
| Nov 30, 2019 | 15.77% |
| Aug 31, 2019 | 10.46% |
| May 31, 2019 | 14.29% |
| Feb 28, 2019 | 14.81% |
| Nov 30, 2018 | 20.85% |
| Aug 31, 2018 | 14.63% |
| May 31, 2018 | -2.80% |
| Feb 28, 2018 | 20.19% |
| Nov 30, 2017 | 20.49% |
| Aug 31, 2017 | 12.24% |
| May 31, 2017 | 9.67% |
| Feb 28, 2017 | 14.73% |
| Nov 30, 2016 | 16.46% |
| Aug 31, 2016 | 10.56% |
| May 31, 2016 | 9.54% |
| Feb 29, 2016 | 10.89% |
| Nov 30, 2015 | 8.39% |
| Aug 31, 2015 | 9.79% |